Buspirone Hydrochloride Tablet
Product Images NDC 68382-182
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 68382-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 02
This is a guide on how to take the prescribed dosage of a medication available in 15 mg and 30 mg tablets. The text shows different ways to split the tablet if a smaller dose is needed, with each dosage size listed next to the corresponding fraction of the tablet to be taken. A visual description of the tablet is also provided.*
3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 03
3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 04
BusPIRone Hydrochloride Tablets, USP, manufactured by CollaGenex Pharmaceuticals, are intended to treat anxiety disorders and alleviate symptoms such as tension, irritability, and lightheadedness. It is important to keep these tablets out of the reach of children. The packaging contains 100 tablets and should be prescribed by a qualified healthcare professional.*
3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 05
3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 06
3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 07
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.